| Patient | Winston Churchill |
|---|---|
| Date of birth | 1874-11-30 |
| Identifiers | MRN HR-ET001-SYN-TD; SSN (made up) 000-01-8846 |
| Document date | 1953-07-15 |
| Author | Beatrice Okafor, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Two-week stroke review at the end of the 21-day dual antiplatelet course. [S]
Mr. Churchill returns three weeks after his stroke and two weeks after his first visit, on the day after his 21-day course of aspirin with clopidogrel ended. Physical and occupational therapy began last week. His left leg is stronger and he walks indoors without the stick; his left hand is still clumsy with buttons and writing, and his speech slurs only when he is tired. His home blood pressure has been 136 to 142 over 78 to 82 on amlodipine 10 mg, without lightheadedness. He has had no new weakness, numbness, speech change, or visual symptoms, and no bleeding or bruising. He has cut down to about five cigars a day but is drinking as before. His mood is a little better, though he still becomes tearful when moved. He saw neurology this morning, and a 30-day heart monitor was fitted. [S]
| Element | Detail |
|---|---|
| Interval change | Leg stronger; walking indoors without a stick; hand still clumsy |
| Home blood pressure | 136 to 142 over 78 to 82 on amlodipine 10 mg |
| Antiplatelet therapy | Aspirin stopped yesterday after 21 days; clopidogrel continues; no bleeding |
| Tobacco and alcohol | About five cigars a day; drinking unchanged |
| Mood | Slightly better; still tearful when moved |
| Rehabilitation | Physical and occupational therapy twice weekly since last week |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tires by late afternoon |
| Neurological | Positive | Left hand clumsy; speech slurs when tired; no new weakness, numbness, or visual loss |
| Cardiovascular | Negative | No chest pain, palpitations, or lightheadedness on standing |
| Hematologic | Negative | No bruising or bleeding |
| Psychiatric | Positive | Low at times and readily tearful; sleeping poorly; no thoughts of death or self-harm |
5 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Aspirin 81 mg delayed-release oral tablet, one tablet by mouth daily for 21 days with clopidogrel | One tablet by mouth daily | Oral route | 1953-06-23 to 1953-07-14 | completed | S |
| Clopidogrel 75 mg oral tablet, one tablet by mouth daily (after a 300 mg loading dose in the hospital) | One tablet by mouth daily | Oral route | 1953-06-23 | active | S |
| Atorvastatin 80 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1953-06-23 | active | S |
| Amlodipine 5 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1953-06-26 to 1953-07-01 | completed | S |
| Amlodipine 10 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1953-07-01 to 1953-07-29 | completed | S |
| Lisinopril 5 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1953-07-15 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1953-07-15 | Body height | 168 | cm | S |
| 1953-07-15 | Body weight | 79.6 | kg | S |
| 1953-07-15 | Body mass index (BMI) [Ratio] | 28.2 | kg/m2 | S |
| 1953-07-15 | Systolic blood pressure | 138 | mm[Hg] | S |
| 1953-07-15 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 1953-07-15 | Heart rate | 70 | /min | S |
| 1953-07-15 | Respiratory rate | 16 | /min | S |
| 1953-07-15 | Body temperature | 36.6 | Cel | S |
| 1953-07-15 | Oxygen saturation in Arterial blood by Pulse oximetry | 96 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1953-07-15 | Total score [NIH Stroke Scale] | 1 | {score} | S |
Vital signs recorded on 1953-07-15; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Alert, articulate, and cheerful in conversation |
| Orthostatic vital signs | Seated 138/80 mmHg; standing 134/78 mmHg with no symptoms |
| Heart | Regular rhythm; no murmur |
| Neurological | NIH Stroke Scale 1 for mild left arm drift; speech clear today; mild left hand slowness on finger tapping |
| Gait | Walks without a stick with slight left circumduction |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Mild left hemiparesis and dysarthria after a right-hemisphere lacunar infarct eight days before intake; synthetic modern episode linked to the documented 1880 stroke | active | confirmed | I69.354 | S — Synthetic modern diagnosis; the 1953 stroke remains D in the history. |
| Essential hypertension | active | confirmed | I10 | S — Synthetic diagnosis supported by the documented raised blood pressure after the 1953 stroke. |
| Nicotine dependence, cigars, six to eight a day | active | confirmed | F17.290 | S — Synthetic coded diagnosis echoing the documented lifelong cigar smoking. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Blood pressure seated and standing, weight and BMI | Every visit | Completed today | Seated 138/80 mmHg, standing 134/78 mmHg; weight 79.6 kg; above the 130/80 target |
| Medication safety | Short-course dual antiplatelet therapy | 21 to 90 days after a minor noncardioembolic stroke, then a single antiplatelet | Completed today | 21 days of aspirin with clopidogrel completed yesterday; clopidogrel continues alone; no bleeding |
| Medication safety | Antithrombotic and statin adherence | Every visit | Completed today | Taking clopidogrel and atorvastatin every day |
| Imaging | Prolonged cardiac rhythm monitoring | At least 30 days within 6 months of the stroke | Ordered | 30-day ambulatory ECG monitor fitted today at the neurology consultation |
| Imaging | Baseline 12-lead ECG | Once after the event | Up to date | Sinus rhythm with left ventricular hypertrophy at the first visit |
| Laboratory | Lipid panel | 4 to 12 weeks after starting or changing a statin, then every 3 to 12 months | Due | Atorvastatin started three weeks ago; due at the eight-week review |
| Laboratory | Basic metabolic panel | 1 to 2 weeks after starting an ACE inhibitor, then every 6 months | Ordered | Lisinopril started today; panel ordered for one to two weeks from now |
| Examination | NIH Stroke Scale | At presentation and with any change | Completed today | 1 (mild left arm drift), down from 2 |
| Examination | Fall-risk assessment | Every visit | Completed today | No falls; walking indoors without a stick |
| Referral | Physical and occupational therapy | At discharge and through recovery | Completed today | Twice weekly since last week |
| Referral | Neurology consultation | After the event | Completed today | Seen today |
| Survey | Depression screen (PHQ-9) | First post-stroke visit, then periodically while symptoms persist; at least yearly | Up to date | 8 at the first visit two weeks ago, item 9 scored 0; repeat at the eight-week review |
| Survey | Cognitive screen (MoCA) | After the event, again within the first year | Up to date | 26 at the first visit; repeat within the year |
| Self-management | Tobacco use | Every visit | Completed today | About five cigars a day; advice to stop; nicotine replacement declined |
| Self-management | Alcohol use | Every visit | Completed today | Drinking unchanged; brief intervention given |
| Self-management | Physical activity | Every visit | Completed today | Walking in the house and garden twice a day as therapy advises |
| Examination | Obstructive sleep apnea evaluation | Consider for all after stroke | Due | Screening questions planned at the eight-week review |
Goal progress:
Guideline basis: 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack (2021); Primary Care of Adult Patients After Stroke: A Scientific Statement From the American Heart Association/American Stroke Association (2021); CMID: Clinical Monitoring Intelligence Database, stroke/TIA, hypertension, and depression monographs (2026)
Follow-up: Basic metabolic panel in one to two weeks. Stroke review in five weeks with a lipid panel and the monitor result. Call 911 for any new stroke symptom. Next scheduled visit 1953-08-19: eight-week stroke and blood pressure review with lipid panel and rhythm-monitor results. [S]